Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V6DF
|
||||
Former ID |
DIB007240
|
||||
Drug Name |
LJP-1207
|
||||
Synonyms |
LJP-1200; LJP-1207; LJP-1233; LJP-1586; SSAO inhibitors (inflammation); SSAO inhibitors, La Jolla; VAP-1 inhibitors, La Jolla; Vascular adhesion protein-1 inhibitors, La Jolla; Semi-carbazide-sensitive amine oxidase, La Jolla
|
||||
Indication | Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] | Investigative | [543706] | ||
Company |
La Jolla Pharmaceutical Co
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(ccc(cc1)OC)/C(=C/F)/CN.Cl
|
||||
Target and Pathway | |||||
Target(s) | Membrane copper amine oxidase | Target Info | Inhibitor | [543706] | |
PANTHER Pathway | Phenylethylamine degradation | ||||
PathWhiz Pathway | Beta-Alanine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.